Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 33487 

STD community-based organizations; 

and the ethics or faith-based 

community. At least four members shall 

be persons with HIV. 

Committee members are Special 

Government Employees (SGEs), 

requiring the filing of financial 

disclosure reports at the beginning of 

and annually during their terms. 

Individuals who are selected for 

appointment will be required to provide 

detailed information regarding their 

financial interests and, for example, any 

work they do for the federal government 

through research grants or contracts. 

Disclosure of this information is 

required in order for CDC ethics officials 

to determine whether there is a conflict 

between the SGE’s public duties as 

members of CHACHSPT and their 

private interests, including an 

appearance of a loss of impartiality as 

defined by federal laws and regulations, 

and to identify any required remedial 

action needed to address the potential 

conflict. CDC and HRSA review 

potential candidates for CHACHSPT 

membership when a vacancy arises and 

provide a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. CDC and HRSA each 

publishes a Federal Register notice and 

will be using a joint process to nominate 

nominees on a rolling basis; thus, 

applications received by CDC will be 

shared with HRSA for consideration. 

Therefore, potential candidates need 

only apply in response to one of the 

Federal Register notices. HHS notifies 

selected candidates of their 

appointment near the start of the term 

in December, or as soon as the HHS 

selection process is completed. Note 

that the need for different expertise 

varies from year to year and a candidate 

who is not selected in one year may be 

reconsidered in a subsequent year. 

SGE nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Candidates 

should submit the following items: 

D A letter of interest or personal 

statement from the nominee stating how 

their expertise would inform the work 

of CHACHSPT 

D A biographical sketch of the 

nominee (500 words or fewer) 

D Current curriculum vitae or resume, 

including complete contact information 

(telephone numbers, mailing address, 

email address) 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. Candidates 

may submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (e.g., CDC, 

National Institutes of Health, Food and 

Drug Administration). 

Nominations may be submitted 

directly by the individual seeking 

nomination or by the person/ 

organization recommending the 

candidate. CDC and HRSA will collect 

and retain nominations received for up 

to two years to create a pool of potential 

CHACHSPT nominees. When a vacancy 

occurs, CDC and HRSA will review 

nominations and may contact nominees 

at that time. 

Appointments shall be made without 

discrimination on the basis of age, race, 

ethnicity, gender, sexual orientation, 

gender identity, HIV status, disability, 

and cultural, religious, or 

socioeconomic status. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–11815 Filed 6–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60-Day–22–0612; Docket No. CDC–2022– 

0074] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Well-Integrated 

Screening and Evaluation for Women 

Across the Nation Reporting System 

(WISEWOMAN). The WISEWOMAN 

program is designed to prevent, detect, 

and control, hypertension and other 

cardiovascular disease (CVD) risk 

factors through services such as health 

coaching, and evidence informed 

lifestyle programs, which are tailored 

for individual and group behavior 

change. 

DATES: CDC must receive written 

comments on or before August 1, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0074 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7118; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 


jspears on DSK121TN23PROD with NOTICES1
33488 Federal Register / Vol. 87, No. 106 / Thursday, June 2, 2022 / Notices 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Well-Integrated Screening and 

Evaluation for Women Across the 

Nation (WISEWOMAN) (OMB Control 

No. 0920–0612, Exp. 8/31/2022)— 

Extension—National Center for Chronic 

Disease and Public Health Promotion 

(NCCDPHP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The WISEWOMAN program, 

sponsored by the CDC, provides services 

to low income, uninsured, or 

underinsured women aged 40–64. The 

WISEWOMAN program is designed to 

prevent, detect, and control 

hypertension and other cardiovascular 

disease (CVD) risk factors through 

healthy behavior support services which 

are tailored for individual and group 

behavior change. The WISEWOMAN 

program provides services to women 

who are jointly enrolled in the National 

Breast and Cervical Cancer Early 

Detection Program (NBCCEDP), which is 

also administered by CDC. 

The WISEWOMAN program is 

administered by state health 

departments and tribal programs. In 

2018, a new five-year cooperative 

agreement was awarded under Funding 

Opportunity Announcement DP18– 

1816, subject to the availability of funds. 

CDC collects two types of information 

from WISEWOMAN awardees, which is 

submitted in an electronic data file to 

CDC twice per year. The Minimum Data 

Elements (MDE) file contains data using 

a unique identifier with client-level 

information about CVD risk factors and 

types of healthy behavior support 

services for participants served by the 

program. The estimated burden per 

response for the MDE file is 24 hours. 

The Annual Progress Report provides a 

narrative summary of each awardee’s 

objectives and the activities undertaken 

to meet program goals. The estimated 

burden per response is 16 hours. 

There are no changes to the 

information collected. CDC will 

continue to use the information 

collected from WISEWOMAN awardees 

to support program monitoring and 

improvement activities, evaluation, and 

assessment of program outcomes. The 

overall program evaluation helps to 

demonstrate program accomplishments 

and strengthen the evidence for strategy 

implementation for improved 

engagement of underserved populations. 

It can also determine whether the 

identified strategies and associated 

activities can be implemented at various 

levels within a state or tribal 

organization. Evaluation is also 

designed to demonstrate how 

WISEWOMAN can obtain 

cardiovascular disease health outcome 

data on at-risk populations, promote 

public education about CVD risk-factors, 

and improve the availability of healthy 

behavior support services for underserved women. 

CDC requests a two-year Extension of 

this data collection. The total estimated 

annual burden hours are 2,240. 

Participation in this information 

collection is required as a condition of 

cooperative agreement funding. There 

are no costs to respondents other than 

their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Aervage 

burden per 

response 

(in hrs.) 

Total burden 

(in hrs.) 

WISEWOMAN Awardees .................. Screening and Assessment and 

Lifestyle Program MDEs.

35 2 24 1,680 

Annual Progress Report ................... 35 1 16 560 

Total ........................................... ........................................................... ........................ ........................ ........................ 2,240 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–11772 Filed 6–1–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–22FS; Docket No. CDC–2022– 

0071] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Artificial Stone 

Countertops: Exposures, Controls, 

Surveillance, & Translation. The 

purpose of the proposed data collection 

is to conduct a survey with artificial 

stone countertop fabrication facilities to 

better understand, work practices and 

controls related to respirable crystalline 

silica, barriers or facilitators to 

implementation of medical and 

exposure monitoring requirements, and 


jspears on DSK121TN23PROD with NOTICES1